Iressa Reviewers
FDA staff who participated in the review of AstraZeneca’s EGFR tyrosine kinase inhibitor gefitinib; a feature of the Pink Sheet’s Drug Review Profile series.
FDA staff who participated in the review of AstraZeneca’s EGFR tyrosine kinase inhibitor gefitinib; a feature of the Pink Sheet’s Drug Review Profile series.